Stem Cells International

Stem Cells and Liver Diseases


Publishing date
01 Mar 2019
Status
Published
Submission deadline
26 Oct 2018

Lead Editor

1National Institutes of Health, Bethesda, USA

2Wuhan University, Wuhan, China

3University of Miami, Coral Gables, USA

4East China Normal University, Shanghai, China


Stem Cells and Liver Diseases

Description

The liver provides essential functions required to maintain homeostasis and health of many organisms. During embryonic development, hepatocytes and biliary epithelial cells arise from the endoderm layer, whereas nonparenchymal liver cells emerge from the mesoderm layer. In the healthy adult liver, hepatocytes have a very slow turnover rate but retain the capacity to rapidly repopulate the liver upon loss of liver mass. Liver stem cells are called upon to regenerate the liver parenchyma when the ability of hepatocyte proliferation is compromised. Over the years, a wealth of knowledge has accumulated pertaining to the cellular and molecular events of liver stem cell activation and differentiation in various animal models and human liver diseases. This knowledge is the driving force to study stem cells in vitro and apply them in laboratory and clinical practice.

Today, we are witnessing an explosion of advances in stem cell technologies. The development of induced pluripotent stem cells (iPSCs) and the differentiation of stem cells into various cell lineages in vitro over the last decade have greatly expanded our ability to model, diagnose, treat, and prevent various diseases. In particular, stem cell-derived hepatocytes have been used for modeling hepatotropic virus infection, virus and host interaction, and high throughput drug screening, as well as hepatocyte transplantation in animal models. Liver stem cells are also a promising tool in gene modification of genetic abnormalities such as metabolic liver diseases and regeneration of the liver in cases of acute liver failure, cirrhosis, and hepatocellular carcinoma.

Despite the recent progress, great challenges remain. For example, differentiation of stem cells into hepatic lineage is stalled at the stage of hepatocyte-like cells (HLC) failing to achieve fully mature hepatocytes. Further development of HLC into fully matured hepatocytes is required to reach the full potential of its research and clinical applications. Gene editing can cause off-target genetic alterations, a serious safety concern for clinical practice. Grafting of the liver stem cells or HLCs in animal models has had only measured success. Overcoming these shortcomings will get us ever closer to the reality of utilizing stem cells in the treatment of various liver diseases.

The purpose of this special issue is to publish high quality research papers and review articles addressing recent advances in the applications of stem cell technologies for the study of molecular mechanisms of hepatocyte growth and differentiation, pathogenesis, modeling, and therapy of liver diseases. Original, high quality contributions that are not yet published or that are not under review by other journals or peer-reviewed conferences will be considered.

Potential topics include but are not limited to the following:

  • New methods for differentiation of hepatic stem cells (including hepatocytes and nonparenchymal cells)
  • Application of stem cells derived hepatocytes for
    • Drug screening
    • Modeling drug metabolism
    • Modeling hepatotropic virus infection and virus/host interaction
    • Gene modification
    • Gene regulation
    • Mechanisms of differentiation
  • Stem cells in liver development, regeneration, and carcinogenesis
  • Novel animal models utilizing stem cell technology for liver diseases study
  • Stem cell-based therapies in liver diseases

Articles

  • Special Issue
  • - Volume 2019
  • - Article ID 9271746
  • - Editorial

Stem Cells and Liver Diseases

Zongyi Hu | Yuchen Xia | ... | Dali Li
  • Special Issue
  • - Volume 2019
  • - Article ID 9605252
  • - Review Article

Stem Cell-Derived Hepatocyte-Like Cells as Model for Viral Hepatitis Research

Jingjing Wang | Bingqian Qu | ... | Yuchen Xia
  • Special Issue
  • - Volume 2019
  • - Article ID 5419501
  • - Research Article

Construction and Evaluation of a Subcutaneous Splenic Injection Port for Serial Intraportal Vein Cell Delivery in Murine Disease Models

Toshio Miki | Chika Takano | ... | Brendan H. Grubbs
  • Special Issue
  • - Volume 2019
  • - Article ID 7896524
  • - Research Article

Oct4 Gene Expression in Primary Colorectal Cancer Promotes Liver Metastasis

Shiki Fujino | Norikatsu Miyoshi
  • Special Issue
  • - Volume 2019
  • - Article ID 5680327
  • - Research Article

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

Ye-Bin Pang | Jian He | ... | Xiao-Ling Luo
  • Special Issue
  • - Volume 2019
  • - Article ID 8451282
  • - Research Article

Notch Inhibition Promotes Differentiation of Liver Progenitor Cells into Hepatocytes via sox9b Repression in Zebrafish

Jacquelyn O. Russell | Sungjin Ko | ... | Donghun Shin
  • Special Issue
  • - Volume 2019
  • - Article ID 2403793
  • - Research Article

Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury

Xiaotian Dong | Xudong Feng | ... | Hongcui Cao
  • Special Issue
  • - Volume 2018
  • - Article ID 7159465
  • - Research Article

Therapeutic Effect of Human Umbilical Cord Mesenchymal Stem Cells at Various Passages on Acute Liver Failure in Rats

Yongting Zhang | Yuwen Li | ... | Chuanlong Zhu
  • Special Issue
  • - Volume 2018
  • - Article ID 9156560
  • - Research Article

The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats

Li Chen | Jiexin Zhang | ... | Shichang Zhang
Stem Cells International
 Journal metrics
Acceptance rate45%
Submission to final decision76 days
Acceptance to publication35 days
CiteScore3.800
Impact Factor3.902
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.